Humacyte Statistics
NASDAQ: HUMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.4454-0.0971 (-17.90%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Humacyte by the numbers
Humacyte has a market capitalization of $123.7 million based on 277.80M shares outstanding. With trailing EPS of $-0.45, Humacyte is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.4% below its 50-day average and 42.0% below its 200-day average.
Average daily trading volume is 5.36M shares, or about $2.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
HUMA valuation vs. peer median
| Metric | HUMA | Peer median | Difference |
|---|---|---|---|
| Market cap | $123.73M | $119.31M | +4% |
| Avg. volume | 5.36M | 1.16M | +362% |
Peer median across 8 companies: CMPX, IVVD, ENGN, ARMP, FATE, CRDL, TARA, STRO.
Valuation
- Market cap
- $123.73M
- Price / sales (latest FY)
- 60.71
- EPS (TTM)
- $-0.45
- Shares outstanding
- 277.80M
Price and trading
- Previous close
- 0.5425
- Open
- 0.513
- Day range
- 0.4444 – 0.52
- 52-week range
- 0.337 – 1.53
- 52-week change
- -63.49%
- 50-day moving average
- 0.4864
- 200-day moving average
- 0.7674
- Beta
- —
- Volume
- 5.77M
- Average volume
- 5.36M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 123.73M
- Forward Pe
- -1.78
- Eps
- -0.45
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.53
- Week52 Low
- 0.34
- Avg Volume
- 5.36M
- Shares Outstanding
- 277.80M
- Ma50
- 0.49
- Ma200
- 0.77
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -70.79%
- Pct From52w Low
- 32.17%